Takahiro Maeda

17PUBLICATIONS
77CO-AUTHORS
Predictive and prognostic markersMolecular targetsBehavioural epidemiologyHaematological tumoursRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 14, 2026
Impact of p53 Target Genes on Drug Resistance in TP53-Mutated B-Cell Precursor Acute Lymphoblastic Leukemia.

|Nov 05, 2025
Guanine nucleotides drive ribosome biogenesis and glycolytic reprogramming in acute myeloid leukemia stem cells.

Gentaro Kawano, Riichiro Ikeda, Daisuke Ishihara

|Oct 29, 2025
Anti-early antigen Epstein-Barr virus titer and atherosclerosis in relation to vascular endothelial growth factor (VEGF) polymorphism rs3025039 among older Japanese individuals.

Yuji Shimizu, Hirotomo Yamanashi, Shin-Ya Kawashiri

|Oct 29, 2025
The XPO7-NPAT axis represents key vulnerabilities in TP53-mutated acute myeloid leukemia.

Yuichiro Semba, Takuji Yamauchi, Daniel E Bauer

|Jul 10, 2024
The RNA helicases DDX19A/B modulate selinexor sensitivity by regulating MCL1 mRNA nuclear export in leukemia cells.

Tatsuya Terasaki, Yuichiro Semba, Kensuke Sasaki

|Jun 24, 2024
Amino acid influx via LAT1 regulates iron demand and sensitivity to PPMX-T003 of aggressive natural killer cell leukemia.

Ryo Yanagiya, Yuji Miyatake, Natsumi Watanabe

Pageof 3

Frequent Collaborators

3 joint publications

Yuichiro Semba

3 joint publications

Hiroshi Imanaga

2 joint publications

Takeshi Inukai

2 joint publications

Hiroshi Handa